Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma

Br J Haematol. 2021 Jan;192(1):212-216. doi: 10.1111/bjh.17121. Epub 2020 Nov 10.

¹ Medicine, University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, USA.
² Medicine, University of Maryland Medical Center, Baltimore, MD, USA.
³ Hematology/Oncology, University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, USA.
⁴ Hematology and Oncology, University of Maryland Medical System, Baltimore, MD, USA.
⁵ Department of Lymphoma and Myleoma, University of Texas MD Anderson Cancer Center Division of Cancer Medicine, Houston, TX, USA.
⁶ Medicine, Greenebaum Cancer Center, University of Maryland, College Park, MD, USA.
⁷ Marlene and Stewart Greenebaum Cancer Center, University of Maryland, College Park, MD, USA.

No abstract available

Keywords: CAR-T; GVHD; HSC TRANSPLANTATION; adoptive cellular therapy.

Publication types